Who owns EFFECTOR THERAPEUTICS INC?
- Ticker: EFTR
- CUSIP Number: 28202v207
Tip: Access positions for across all investors
Analyze quarterly positions in Effector Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Effector Therapeutics stock
Who bought or sold EFFECTOR THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sabby Management | 62k | $2.3k | -82% | Sep 2024 |
|
| Barclays | 100.00 | $0 | 0% | Sep 2024 |
|
Who sold out of Effector Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alyeska Investment Group | Jun 2024 | 365k | $106k |
| Carlyle | Jun 2024 | 193k | $56k |
| UBS Group | Jun 2024 | 62k | $18k |
| Geode Capital Management | Jun 2024 | 26k | $7.4k |
| Vanguard Group | Jun 2024 | 25k | $7.3k |
| Hrt Financial | Jun 2024 | 22k | $6.0k |
| Jane Street | Jun 2024 | 19k | $5.4k |
| Virtu Financial | Jun 2024 | 18k | $5.0k |
| Two Sigma Investments | Jun 2024 | 11k | $3.2k |
| Sea Otter Advisors | Jun 2024 | 11k | $3.1k |
| Tower Research Capital | Jun 2024 | 9.8k | $2.8k |
| Royal Bank of Canada | Jun 2024 | 546.00 | $0 |